The mRNA industry is presently experiencing substantial growth, fueled by the promising deployment of mRNA-based immunizations against COVID-19. Research indicate a complex landscape, with ongoing capital into therapeutic applications outside infectious diseases, including areas such as oncology, rare diseases, and protein replacement therapy. Geog